ALBIX

Welcome to the Brand page for “ALBIX”, which is offered here for Line 33, in the field of development of medicines and pharmaceutical products should be inserted after cells in class 42.;pharmaceutical products and substances; reagents * for pharmaceutical and medical use * ; diagnostic reagents * for medical use * ; proteins * for pharmaceutical and medical use * ; albumin * for pharmaceutical and medical use * ; recombinant albumin * for pharmaceutical and medical use * ; diagnostic imaging agents;in the statement, page 1, lines 5 - 11, chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, proteins for industrial use; should be deleted, and, in the statement, page 1, lines 15-17, ; chemical substances for use in tissue culture, cell growth media for growing animal cells, stem cells and cell therapy preparations should be deleted, and, in the statement, page 1, line 19, after reagents, for pharmaceutical and medical use should be inserted, and, in the statement, page 1, line 20 after reagents, for medical use should be inserted, and, in the statement, page 1, line 20, after proteins, for pharmaceutical and medical use should be inserted, and, in the statement, page 1, line 20, after albumin, for pharmaceutical and medical use should be inserted, and, in the statement, page 1, line 20, after, recombinant albumin, for pharmaceutical and medical use should be inserted, and, in the statement, page 2, line 1, after all relating to, the use of albumin in should be inserted.;[ chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, proteins for industrial use; ] albumin for use in the manufacture of pharmaceuticals, vaccines, medical substances and cell therapy preparations; chemical substances for use in diagnostic kits, albumin blocking agents used to bind to test kit surfaces to prevent non-specific binding of test substances to the surface [ ; chemical substances for use in tissue culture, cell growth media for growing animal cells, stem cells and cell therapy preparations ];scientific and technological research and development services for new products and uses in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; consultancy services regarding product research and product development in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cell research; advisory services with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; providing expert analysis with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cells * in the field of development of medicines and pharmaceutical products *; and scientific development and analysis in the fields of pharmaceuticals, vaccines, and drug discoveries; all relating to * the use of albumin in * science, biotechnology, biochemistry, biology, medicine and pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “ALBIX” is believed to be currently owned by “ALBUMEDIX LTD”.